Home › NDC Lookup › RxCUI directory › RxCUI 310687

Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Suspension — RxCUI 310687

RxNorm drug concept · Semantic clinical drug
RxCUI 310687 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310687
Official nameHydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashydrocortisone 10 MG / neomycin 3.5 MG / polymyxin B 10,000 UNT per 1 ML Otic Suspension; hydrocortisone 10 MG (1 % ) / neomycin sulfate 3.5 MG / polymyxin B sulfate 10,000 UNT per mL Otic Suspension
FDA products mapped14
Package NDCs mapped14
Reported Medicaid activity (SDUD)201,395 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydrocortisone Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • This is a corticosteroid enema used specifically for ulcerative colitis that affects the lower part of your colon — the rectum and the left side. Rather than treating the whole bod...
  • What exactly is this enema treating — is it the same as regular colitis medicine?
  • Many people notice symptoms like diarrhea and bleeding improving within 3 to 5 days. That said, the actual healing of the colon lining often takes longer to show up — sometimes wee...
  • How long do I need to use it before it starts working?
📖 Read our full Hydrocortisone Rectal guide →

🕸️ Concept Web — How Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / p... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Suspension RxCUI 310687

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Hydrocortisone 5492
    • Neomycin 7299
    • Polymyxin B 8536
    • Hydrocortisone / neomycin / polymyxin B 217627
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Oticin HC 763092
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydrocortisone / neomycin / polymyxin B Otic Suspension 375450
    • Hydrocortisone / neomycin / polymyxin B Otic Product 1163423
    • Hydrocortisone / neomycin / polymyxin B Otic Suspension [Oticin HC] 763094
    • Oticin HC Otic Product 1185166
    • Otic Suspension 316974
    • Otic Product 1151134
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Hydrocortisone 10 MG/ML 316057
    • Neomycin 3.5 MG/ML 316332
    • Polymyxin B 10000 UNT/ML 316526
    • Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Suspension [Oticin HC] 763095
    • Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML [Oticin HC] 763093

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydrocortisone 10 MG/ML SCDC · 316057
  • Neomycin 3.5 MG/ML SCDC · 316332
  • Polymyxin B 10000 UNT/ML SCDC · 316526
  • Hydrocortisone / neomycin / polymyxin B Otic Suspension SCDF · 375450
  • Hydrocortisone / neomycin / polymyxin B Otic Product SCDG · 1163423

Brand-Name Concepts

  • Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML Otic Suspension [Oticin HC] SBD · 763095
  • Hydrocortisone 10 MG/ML / neomycin 3.5 MG/ML / polymyxin B 10000 UNT/ML [Oticin HC] SBDC · 763093
  • Hydrocortisone / neomycin / polymyxin B Otic Suspension [Oticin HC] SBDF · 763094
  • Oticin HC Otic Product SBDG · 1185166
  • Oticin HC BN · 763092

📦 FDA Products & Package NDCs

14 products · 14 package NDCs
14 package NDCs map to RxCUI 310687 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24208-0635-62 1 BOTTLE, DROPPER in 1 CARTON (24208-635-62) / 10 mL in 1 B... Neomycin and Polymyxin B Sulfates and Hydrocortisone Bausch & Lomb Incorporated 1996-08-28
50090-0431-00 1 BOTTLE, DROPPER in 1 CARTON (50090-0431-0) / 10 mL in 1 B... Neomycin and Polymyxin B Sulfates and Hydrocortisone A-S Medication Solutions 2016-06-29
50090-2365-00 10 mL in 1 BOTTLE, PLASTIC (50090-2365-0) Neomycin and Polymyxin B Sulfates and Hydrocortisone A-S Medication Solutions 2016-04-22
50090-6336-00 1 BOTTLE in 1 CARTON (50090-6336-0) / 10 mL in 1 BOTTLE Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension A-S Medication Solutions 2023-01-18
60219-2084-06 1 BOTTLE, PLASTIC in 1 CARTON (60219-2084-6) / 10 mL in 1 B... NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE Amneal Pharmaceuticals NY LLC 2025-09-30
61314-0645-11 10 mL in 1 BOTTLE, PLASTIC (61314-645-11) Neomycin and Polymyxin B Sulfates and Hydrocortisone Sandoz Inc. 2003-03-17
63187-0308-10 1 BOTTLE, DROPPER in 1 CARTON (63187-308-10) / 10 mL in 1 B... Neomycin and Polymyxin B Sulfates and Hydrocortisone Proficient Rx LP 2016-05-02
63187-0648-10 10 mL in 1 BOTTLE, PLASTIC (63187-648-10) Neomycin and Polymyxin B Sulfates and Hydrocortisone Proficient Rx LP 2018-12-01
63629-8844-01 10 mL in 1 BOTTLE, PLASTIC (63629-8844-1) Neomycin and Polymyxin B Sulfates and Hydrocortisone Bryant Ranch Prepack 2021-09-10
64980-0448-01 1 BOTTLE in 1 CARTON (64980-448-01) / 10 mL in 1 BOTTLE Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension Rising Pharma Holdings, Inc. 2019-03-15
68071-4229-01 10 mL in 1 BOX (68071-4229-1) Neomycin and Polymyxin B Sulfates and Hydrocortisone NuCare Pharmaceuticals,Inc. 2018-01-12
68788-7787-01 1 BOTTLE in 1 CARTON (68788-7787-1) / 10 mL in 1 BOTTLE Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension Preferred Pharmaceuticals, Inc. 2020-10-21
68788-8130-01 10 mL in 1 BOTTLE, PLASTIC (68788-8130-1) Neomycin and Polymyxin B Sulfates and Hydrocortisone Preferred Pharmaceuticals Inc. 2022-02-03
68788-9924-01 1 BOTTLE, DROPPER in 1 CARTON (68788-9924-1) / 10 mL in 1 B... Neomycin and Polymyxin B Sulfates and Hydrocortisone Preferred Pharmaceuticals, Inc. 2012-01-18
Observed labelers: A-S Medication Solutions (3) · Preferred Pharmaceuticals, Inc. (2) · Proficient Rx LP (2) · Amneal Pharmaceuticals NY LLC (1) · Bausch & Lomb Incorporated (1) · Bryant Ranch Prepack (1) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.